| Autor: |
Melamed-Gal S; Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel., Loupe P; Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel., Timan B; Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel., Weinstein V; Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel., Kolitz S; Immuneering Corporation Boston, MA, USA., Zhang J; Immuneering Corporation Boston, MA, USA., Funt J; Immuneering Corporation Boston, MA, USA., Komlosh A; Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel., Ashkenazi N; Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel., Bar-Ilan O; Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel., Konya A; Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel., Beriozkin O; Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel., Laifenfeld D; Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel., Hasson T; Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel., Zeskind B; Immuneering Corporation Boston, MA, USA., Hayden M; Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel., Nock S; Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel., Grossman I; Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel. |
